Evidence map›Paper›PMID 28530200›Full record

ArticleIET nanobiotechnology2017

Antioxidant, antibacterial and anticancer properties of phyto

Farinaz Ghanbar, Amir Mirzaie, Fatemeh Ashrafi, Hassan Noorbazargan, Mojgan Dalirsaber Jalali, Soheil Salehi, Seyed Ataollah Sadat Shandiz

Abstract read
In one paragraph

Article in IET nanobiotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Green Synthesis and Quality-by-Design Optimization ofMolecules (Basel, Switzerland) · 2026
    Article
  2. Metal and Metal Oxide Nanoparticles UsingPlants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Green Synthesis of Nanomaterials.Nanomaterials (Basel, Switzerland) · 2021
    Review
  11. Secondary Metabolites fromMolecules (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Farinaz GhanbarDepartment of Biology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Amir MirzaieYoung Researchers and Elite Club, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Fatemeh AshrafiDepartment of Biology, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Hassan NoorbazarganDepartment of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mojgan Dalirsaber JalaliDepartment of Microbiology, Faculty of Basic Science, Young Researcher Club, Lahijan Branch, Islamic Azad University, Lahijan, Iran.
Soheil SalehiDepartment of Phytochemistry and Essential Oils Technology, Faculty of Pharmaceutical Chemistry, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran.
Seyed Ataollah Sadat ShandizYoung Researchers and Elite Club, East Tehran Branch, Islamic Azad University, Tehran, Iran. Atashandiz@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The focus of this study is on a rapid and cost-effective approach for the synthesis of silver nanoparticles (AgNPs) using

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsArtemisiaBacterial Physiological PhenomenaCell SurvivalDose-Response Relationship, DrugDrug CompoundingFungiHEK293 CellsHeLa CellsHT29 CellsHumansMaterials TestingMCF-7 CellsMetal NanoparticlesAnti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsPlant ExtractsSilver

Identifiers

PMID28530200
PMCPMC8676429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.